Logo

Log In Sign Up |  An official publication of: American College of Emergency Physicians
Navigation
  • Home
  • Multimedia
    • Podcasts
    • Videos
  • Clinical
    • Airway Managment
    • Case Reports
    • Critical Care
    • Guidelines
    • Imaging & Ultrasound
    • Pain & Palliative Care
    • Pediatrics
    • Resuscitation
    • Trauma & Injury
  • Resource Centers
    • mTBI Resource Center
  • Career
    • Practice Management
      • Benchmarking
      • Reimbursement & Coding
      • Care Team
      • Legal
      • Operations
      • Quality & Safety
    • Awards
    • Certification
    • Compensation
    • Early Career
    • Education
    • Leadership
    • Profiles
    • Retirement
    • Work-Life Balance
  • Columns
    • ACEP4U
    • Airway
    • Benchmarking
    • Brief19
    • By the Numbers
    • Coding Wizard
    • EM Cases
    • End of the Rainbow
    • Equity Equation
    • FACEPs in the Crowd
    • Forensic Facts
    • From the College
    • Images in EM
    • Kids Korner
    • Medicolegal Mind
    • Opinion
      • Break Room
      • New Spin
      • Pro-Con
    • Pearls From EM Literature
    • Policy Rx
    • Practice Changers
    • Problem Solvers
    • Residency Spotlight
    • Resident Voice
    • Skeptics’ Guide to Emergency Medicine
    • Sound Advice
    • Special OPs
    • Toxicology Q&A
    • WorldTravelERs
  • Resources
    • ACEP.org
    • ACEP Knowledge Quiz
    • Issue Archives
    • CME Now
    • Annual Scientific Assembly
      • ACEP14
      • ACEP15
      • ACEP16
      • ACEP17
      • ACEP18
      • ACEP19
    • Annals of Emergency Medicine
    • JACEP Open
    • Emergency Medicine Foundation
  • About
    • Our Mission
    • Medical Editor in Chief
    • Editorial Advisory Board
    • Awards
    • Authors
    • Article Submission
    • Contact Us
    • Advertise
    • Subscribe
    • Privacy Policy
    • Copyright Information

Is There an Increased Incidence of COVID-Related Myocarditis in Kids?

By Landon Jones, MD and Richard M. Cantor, MD, FAAP, FACEP | on February 19, 2021 | 0 Comment
Kids korner
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
Print-Friendly Version
Chest X-ray of a 16-year-old boy with myocarditis.
Dr. P. Marazzi / ScienceSource. Chest X-ray of a 16-year-old boy with myocarditis. 

Is there an increased incidence of COVID-related myocarditis in children?

Viruses are the most common cause of pediatric myocarditis. In general, the most common viruses causing pediatric myocarditis are Coxsackievirus B, other enteroviruses, influenza, rubella, and adenovirus.1 During and after important viral outbreaks, including the original 2002 severe acute respiratory syndrome (SARS), 2012 Middle Eastern respiratory syndrome (MERS), and 2009 H1N1 influenza A, increases in cardiac abnormalities in adults (suggesting cardiac association with these viruses) have been reported.2,3 

You Might Also Like
  • Incidence of COVID-19 in Children
  • New Research Broadens Our Understanding of COVID-19 in Kids
  • The Safety of Ibuprofen in Children with COVID-19
Explore This Issue
ACEP Now: Vol 40 – No 02 – February 2021

We are unable to find any articles addressing association between either the original 2002 SARS or MERS with myocarditis in children. Regarding the 2009/2010 H1N1 influenza outbreak, however, reports from pediatric ICUs in the United States and Japan suggested myocarditis incidence of around 1 to 2 percent in these patients (n=8 cases total).4,5 

Clinically, the incidence of myocarditis is important to know. Animal studies have demonstrated that exercising with myocarditis is associated with an increase in viral replication, which can result in permanent cardiac scarring. Whether this translates to humans including children is unknown. However, myocarditis has been shown to account for 20 percent of nontraumatic sudden cardiac deaths among a military recruit cohort, suggesting that any children who acquire myocarditis may carry downstream risks into early adulthood.6 

More recently, a systematic review specifically evaluated pediatric COVID-19–associated myocarditis.7 The authors found that, as of July 2020, there were 570 Centers for Disease Control and Prevention (CDC)–reported cases of pediatric multisystem inflammatory syndrome (PMIS). PMIS is more routinely referred to as MIS-C (multisystem inflammatory syndrome in children) in much of the emerging literature on this topic. The condition is a Kawasaki-like hyperinflammatory disease presentation involving multiple organ systems and often accompanying myocardial dysfunction. As of the end of July 2020, the authors calculated an incidence of CDC-reported MIS-C of approximately 0.2 to 0.6 percent of COVID-19 pediatric infections. In their systematic review, the authors identified 688 cases of MIS-C in the literature, with myocardial dysfunction documented in 340 of 688 of these cases (50.9 percent). Of note, isolated COVID-19–associated myocarditis cases have been reported in the literature, but most cases of myocarditis are related to MIS-C.

The overall incidence of COVID-19–associated myocarditis is difficult to estimate using these data, as these studies reported MIS-C patients in pediatric ICUs only. The incidence of less severe myocarditis is unknown in both patients with COVID-19 and influenza patients. 

Is COVID-19 especially likely to cause myocarditis? That remains unknown. The incidence of COVID-19–associated myocarditis may turn out to be similar to other viral pathogens, but due to the vast number of COVID-19 infections, the prevalence of COVID-19–associated myocarditis definitely appears to be higher. For this reason alone, myocarditis needs to be higher on practitioners’ differential diagnosis list when evaluating children in today’s clinical environment. 

While of uncertain clinical significance, there is a small amount of data on asymptomatic COVID-19–associated myocarditis in college student athletes (mean age of 20 years). A single study from Vanderbilt University evaluated 59 COVID-19–positive athletes, of whom 78 percent had mild symptoms and 22 percent were asymptomatic. These data were compared to results of 60 athlete controls and 27 healthy controls via cardiac magnetic resonance (CMR).8 The median time from COVID-19 detection to CMR was 21.5 days (range 10–162 days), and two of 59 (3 percent) COVID-19–positive patients met clinical criteria for myocarditis. Again, the clinical significance of these findings remains uncertain, and this study was not in children. Still, it does warrant consideration that something similar may be happening in children, too. 

Pages: 1 2 | Single Page

Topics: COVID-19myocarditisPediatrics

Related

  • Dr. Joe Sachs and “The Pitt” Are Redefining Public Health Education Through Storytelling

    June 11, 2025 - 0 Comment
  • June 2025 News from the College

    June 5, 2025 - 0 Comment
  • Influenza, Muscle Pain, and an Elevated Serum Creatine Kinase

    May 10, 2025 - 0 Comment

Current Issue

ACEP Now May 03

Download PDF

Read More

About the Authors

Landon Jones, MD

Dr. Jones is associate professor and pediatric emergency medicine fellowship director at the University of Kentucky Department of Emergency Medicine & Pediatrics in Lexington, Kentucky.

View this author's posts »

Richard M. Cantor, MD, FAAP, FACEP

Dr. Cantor is professor of emergency medicine and pediatrics, director of the pediatric emergency department, and medical director of the Central New York Regional Poison Control Center at Upstate Medical University in Syracuse, New York.

View this author's posts »

No Responses to “Is There an Increased Incidence of COVID-Related Myocarditis in Kids?”

Leave a Reply Cancel Reply

Your email address will not be published. Required fields are marked *


*
*

Wiley
  • Home
  • About Us
  • Contact Us
  • Privacy
  • Terms of Use
  • Advertise
  • Cookie Preferences
Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 2333-2603